Tubulointerstitial nephritis caused by the antiviral agent foscarnet
- 1 January 1989
- journal article
- Published by Frontiers Media SA in Transplant International
- Vol. 2 (1) , 223-227
- https://doi.org/10.1111/j.1432-2277.1989.tb01871.x
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Treatment of Cytomegalovirus Retinitis with Trisodium Phosphonoformate Hexahydrate (Foscarnet)The Journal of Infectious Diseases, 1988
- Clinical Approach to Infection in the Compromised HostPublished by Springer Nature ,1988
- FOSCARNET-INDUCED ACUTE RENAL FAILURE AND EFFECTIVENESS OF HAEMODIALYSISThe Lancet, 1987
- Treatment of cytomegalovirus pneumonitis with foscarnet (trisodium phosphonoformate) in patients with AIDSJournal of Medical Virology, 1987
- Leukocyte C5a receptor modulation during hemodialysisKidney International, 1987
- Inhibition of human renal epithelial Na+/Pi cotransport by phosphonoformic acidBiochemical and Biophysical Research Communications, 1986
- Pharmacokinetics, safety and preliminary clinical experiences using foscarnet in the treatment of cytomegalovirus infections in bone marrow and renal transplant recipientsJournal of Antimicrobial Chemotherapy, 1986
- ADVERSE EFFECT OF TRIMETHOPRIM ON KIDNEY FUNCTION IN RENAL TRANSPLANT PATIENTSThe Lancet, 1984
- Renal function after acyclovir intravenous injectionThe American Journal of Medicine, 1982
- DETERIORATION IN RENAL FUNCTION IN ASSOCIATION WITH CO-TRIMOXAZOLE THERAPYThe Lancet, 1973